Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells

Journal of Cellular Physiology

Volumn 167, Issue 2, 1996, Pages 333-340

  Lim, Young Tak ^c   Sugiura, Yasuo ^a   Laug, Walter E ^a   Sun, Bo ^a   Garcia, Andrew ^a   DeClerck, Yves A ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE B; METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

APROTININ; BLOTTING, NORTHERN; CARCINOGENS; COLLAGENASES; ENZYME PRECURSORS; FIBRINOLYTIC AGENTS; FIBROSARCOMA; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; PROTEASE INHIBITORS; PROTEINS; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0029962937     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199605)167:2<333::AID-JCP18>3.0.CO;2-8     Document Type: Article

References (50)

1. Blasi, F., and Verde, P. (1990) Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol., 1:117-126.
2. Campbell, C.E., Flenniken, A.M., Skup, D., and Williams, B.R. (1991) Identification of a serum-and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem., 266:7199-7206.
3. Chirgwin, J.M., Przybyla, A.E., McDonald, R.J., and Rotter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18:5294-5299.
4. Chiu, R., Imagawa, M., Imbra, R.J., Bockoven, J.R., and Karin, M. (1987) Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature, 329:648-651.
5. DeClerck, Y.A., and Imren, S. (1994) Protease inhibitors: Role and potential therapeutic use in human cancer. Eur. J. Cancer, 30A:2170-2180.
6. DeClerck, Y.A., and Laug, W.E. (1993) The role of the extracellular matrix in tumor invasion, metastasis and angiogenesis. In: Drug Resistance in Oncology. B.A. Teicher, ed. Marcel Dekker, New York, pp. 121-163.
7. DeClerck, Y.A., Darville, M.I., Eeckhout, Y., and Rousseau, G.G. (1994) Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene, 139:185-191.
8. Ellis, V., Wun, T.C., Behrendt, N., Ronne, E., and Dano, K. (1990) Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J. Biol. Chem., 265:9904-9908.
9. Fridman, R., Lacal, J.C., Reich, R., Bonfil, D.R., and Ahn, C.H. (1990) Differential effects of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells. J. Cell. Physiol., 142:55-60.
10. Gettins, P., Patston, P.A., and Schapira, M. (1992) Structure and mechanism of action of serpins. Hematol. Oncol. Clin. North Am., 6:1393-1408.
11. Goldberg, G.I., Marmer, B.L., Grant, G.A., Eisen, A.Z., Wilhelm, S., and He, C.S. (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. U. S. A., 86:8207-8211.
12. Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T., and Marmer, B.L. (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem., 267:4583-4591.
13. Gutman, A., and Wasylyk, B. (1990) The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J., 9:2241-2246.
14. Hanemaaijer, R., Koolwijk, P., Le Clercq, L., de Vree, W.J., and van Hinsbergh, V.W. (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J., 296:803-809.
15. He, C.S., Wilhelm, S.M., Pentland, A.P., Manner, B.L., Grant, G.A., Eisen, A.Z., and Goldberg, G.I. (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. U. S. A., 86:2632-2636.
16. Houde, M., de Bruyne, G., Bracke, M., Ingelman Sundberg, M., Skoglund, G., Masure, S., Van Damme, J., and Opdenakker, G. (1993) Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int. J. Cancer, 53:395-400.
17. Huhtala, P., Chow, L.T., and Tryggvason, K. (1990) Structure of the human type IV collagenase gene. J. Biol. Chem., 265:11077-11082.
18. Huhtala, P., Tuuttila, A., Chow, L.T., Lohi, J., Keski Oja, J., and Tryggvason, K. (1991) Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem., 266:16485-16490.
19. Keski Oja, J., Lohi, J., Tuuttila, A., Tryggvason, K., and Vartio, T. (1992) Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp. Cell Res., 202:471-476.
20. Kleiner, D.E., Jr., and Stetler Stevenson, W.G. (1993) Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol., 5:891-897.
21. Kruithof, E.K. (1988) Plasminogen activator inhibitors - a review. Enzyme, 40:113-121.
22. Kwaan, H.C. (1992) The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev., 12:291-311.
23. 4. Nature, 277:680-685.
24. Laug, W.E., Cao, X.R., Yu, Y.B., Shimada, H., and Kruithof, E.K. (1993) Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Cancer Res., 53:6051-6057.
25. Mackay, A.R., Ballin, M., Pelina, M.D., Farina, A.R., Nason, A.M., Hartzler, J.L., and Thorgeirsson, U.P. (1992) Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12:168-184.
26. Matrisian, L.M. (1992) The matrix degrading metalloproteinases. Bioessays, 14:455-463.
27. Medcalf, R.L., Ruegg, M., and Schleuning, W.D. (1990) A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperates in basal expression and conveys activation by phorbol ester and cAMP. J. Biol. Chem., 265:14618-14626.
28. Mignatti, P., Robbins, E., and Rifkin, D.B. (1986) Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell, 47:487-498.
29. Montgomery, A.M., De Clerck, Y.A., Langley, K.E., Reisfeld, R.A., and Mueller, B.M. (1993) Melanoma-mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res., 53:693-700.
30. Murphy, G., and Docherty, A.J. (1992) The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol., 7:120-125.
31. Murphy, G., Reynolds, J.J., and Werb, Z. (1985) Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J. Biol. Chem., 260:3079-3083.
32. Murphy, G., Ward, R., Gavrilovic, J., and Atkinson, S. (1992) Physiological mechanisms for metalloproteinase activation. Matrix Suppl., 1:224-230.
33. Murphy, P.G., Frank, C.B., and Hart, D.A. (1993) Characterization of the plasminogen activators and plasminogen activator inhibitors expressed by cells isolated from rabbit ligament and synovial tissues: Evidence for unique cell populations. Exp. Cell Res., 205:16-24.
34. Nerlov, C., Rorth, P., Blasi, F., and Johnsen, M. (1991) Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene, 6:1583-1592.
35. Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308:693-698.
36. Pei, D., and Weiss, S.J. (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature, 375:244-247.
37. Pei, D., Majmudar, G., and Weiss, S.J. (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem., 269:25849-25855.
38. Riccio, A., Lund, L.R., Sartorio, R., Lania, A., Andreasen, P.A., Dano, K., and Blasi, F. (1988) The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. Nucleic Acids Res., 16:2805-2824.
39. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370:61-65.
40. Schuster, W.A., Medcalf, R.L., and Kruithof, E.K. (1993) Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Endocrinology, 133:1724-1730.
41. Shapiro, S.D., Kobayashi, D.K., and Welgus, H.G. (1992) Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J. Biol. Chem., 267:13890-13894.
42. Stetler Stevenson, W.G., Brown, P.D., Onisto, M., Levy, A.T., and Liotta, L.A. (1990) Tissue inhibitor of metalloproteinases-2 (TMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem., 265:13933-13938.
43. Strongin, A., Collier, I.E., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1995) Mechanism of cell surface activation of 72 kDa type IV collagenase. J. Biol. Chem., 270:5331-5338.
44. Strongin, A.Y., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TEMP-2. J. Biol. Chem., 268:14033-14039.
45. Van Wart, H.E., and Birkedal Hansen, H. (1990) The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A., 87:5578-5582.
46. Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J., Reynolds, J.J., and Murphy, G. (1991) Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta, 1079:242-246.
47. Ward, R.V., Atkinson, S.J., Reynolds, J.J., and Murphy, G. (1994) Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem. J., 304:263-269.
48. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/ type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion. J. Cell Sci., 104:991-999.
49. Welgus, H.G., Jeffrey, J.J., Eisen, A.Z., Roswit, W.T., and Stricklin, G.P. (1985) Human skin fibroblast collagenase: Interaction with substrate and inhibitor. Collagen Rel. Res., 5:167-179.
50. Yu, M., Sato, H., Seiki, M., and Thompson, E.W. (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res., 55:3272-3277.